Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg-Reference-Cited by-同舟云学术

Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg

Published:1992-08-07 Issue:5071 Volume:257 Page:789-792
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Lenschow Deborah J.¹,Zeng Yijun²,Thistlethwaite J. Richard²,Montag Anthony³,Brady William⁴,Gibson Marylou G.⁴,Linsley Peter S.⁴,Bluestone Jeffrey A.¹

Affiliation:

1. Ben May Institute and the Committee on Immunology, University of Chicago, Chicago, IL 60637.

2. Department of Surgery, University of Chicago, Chicago, IL 60637.

3. Department of Pathology, University of Chicago, Chicago, IL 60637.

4. Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference24 articles.

1. BRUNET, J.F., A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4, NATURE 328: 267 (1987).

2. DAMLE, N.K., DIFFERENTIAL COSTIMULATORY EFFECTS OF ADHESION MOLECULES B7, ICAM-1, LFA-3, AND VCAM-1 ON RESTING AND ANTIGEN-PRIMED CD4+ LYMPHOCYTES-T, JOURNAL OF IMMUNOLOGY 148: 1985 (1992).

3. Prevention of Xenograft Rejection by Masking Donor HLA Class I Antigens

4. GILL, R.G., CHARACTERIZATION OF PRIMARY T-CELL SUBSETS MEDIATING REJECTION OF PANCREATIC-ISLET GRAFTS, JOURNAL OF IMMUNOLOGY 143: 2176 (1989).

5. HAO, L, ROLE OF THE L3T4+ T-CELL IN ALLOGRAFT-REJECTION, JOURNAL OF IMMUNOLOGY 139: 4022 (1987).

Cited by 1102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically engineered hypoimmunogenic cell therapy;Nature Reviews Bioengineering;2024-07-29

2. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?;Pharmaceuticals;2024-07-26

3. Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy;Cancer Immunology Research;2024-06-03

4. Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes;Expert Opinion on Investigational Drugs;2024-03-13

5. Fish Uses CTLA-4 Immune Checkpoint to Suppress mTORC1-Controlled T-Cell Glycolysis and Immunity;The Journal of Immunology;2024-02-16